Aktuelle Masterarbeitsthemen der Forschungsgruppe Molekulare Pharmazie
Current Master's Theses-Projects of the Research Group in Molecular Pharmacy

 

Forschungsgebiet
Research Field
Kontakt Betreuer/in
Contact Supervisor
MSc PharmazieMSc Drug SciencesBemerkungen
Comments
Integrin Receptor-Targeted Immune Modulation: Target Production, Bioassay Development and Evaluation of InhibitorsCarla Plüssjaja 
Development of Carbohydrate-based Mimics as Ligands for Siglec-8PD Dr. Oliver SchwardtjaneinProject description

Synthesis and development of carbohydrate-based molecules to reduce pathogen virulence

Dr. Rachel Heveyneinja 

Design, synthesis, and evaluation of carbohydrate-based modulators of host defense

Dr. Rachel Heveyneinja 
     
no longer available
Protein engineering for the development of parasite-derived inhibitors of host defense pathway initiation
Aleksandra BlagojevicjajaProject description
no longer available
Discovery and evaluation of novel complement inhibitors using phage-display library screening and peptide synthesis.
Dr. Christina Lamersjaja 
no longer available
Protection of transplants and biomaterial from immune attack: development of model systems and therapeutic strategies.
Dr. Ekaterina Umnyakovajaja 
no longer available
Synthesis and development of glycopolymers for treating blood group-incompatible transplantations
Dr. Rachel HeveyjajaCollaboration with University Start-up Polyneuron Pharmaceuticals AG
no longer available
Evaluation of physiological or therapeutic immune modulators of the complement/coagulation system.
Dr. Richard Pouwjaja 
no longer available
In vitro assessment of glycopolymers for enabling blood group-incompatible transplantations
Dr. Rachel HeveyjajaCollaboration with University Start-up Polyneuron Pharmaceuticals AG
no longer available
Cloning, expression, purification and evaluation of therapeutically relevant proteins involved in the modulation of immune and inflammatory responses.
Dr. Said RabbanijajaProject description
no longer available
Discovery and evaluation of novel complement inhibitors using phage-display library screening and peptide synthesis.
Dr. Pascal HänggijajaCollaboration with University Start-up Polyneuron Pharmaceuticals AG; first contact Prof. Dr. Daniel Ricklin and Dr. Pascal Hänggi

no longer available
Point-of-Care-Diagnostics for Preeclampsia (Development of sensitive, antibody-based in-vitro diagnostic rapid tests)

Prof. Dr. Daniel RicklinneinjaExternal master’s thesis with MOMM Diagnostics GmbH and FHNW. Preferred project start in August 2021 or earlier;
first contact Prof. Dr. Daniel Ricklin
no longer available
Preparation of protein-based targets and modulators of the innate immune system and their evaluation in bioassays.
Dr. Said Rabbanijaja 
no longer available
Design and synthesis of glycomimetic ligands for Siglec-8, a new target for eosinophil and mast-cell related disorders.
Benedetta Girardijaja 
no longer available
Removal of autoantibodies against glycans - Biological and biophysical characterization of autoantibody-glycopolymer complexes
Butrint AliujajaCollaboration with University Start-up Polyneuron Pharmaceuticals AG; 
no longer available
Beyond anti-glycan autoantibody removal - In vivo and in vitro assessment of the immune modulatory potential of glycopolymers for the treatment of autoimmune diseases
Dr. Emilie SeydouxjajaCollaboration with University Start-up Polyneuron Pharmaceuticals AG; 
no longer available
Novel Anti-Inflammatories: Identification of Selectin Antagonists by a Dynamic Combinatorial Chemistry Approach
Prof. em. Dr. Beat Ernstjajapreferred MSc Drug Sciences
no longer available
Evaluation and Summarization Praktikum
PD Dr. Oliver Schwardtjaja 

no longer available
Development of a new class of radiopharmaceuticals for diagnosis and therapy of CXCR4-expressing malignancies

Prof. Dr. Daniel RicklinjajaCollaboration with Universitätsspital Basel
Project description
no longer available
Establishment and validation of a Mannan-induced psoriasis arthritis-like disease model in mice
Prof. Dr. Daniel RicklinneinjaMasterthesis with Idorsia; first contact Prof. Dr. Daniel Ricklin
no longer available
Protein engineering for the development of inhibitors of host defense pathway initiation.
Kevin Widmerjaja 
no longer available
Discovery and synthesis of CD59 inhibitors to potentiate antibody-based leukemia treatment
Dr. Christina Lamersjaja 
no longer available
DC-SIGN Antagonists to Block the Viral Entry to Dendritic Cells
Dr. Jonathan Cramerjajapreferred MSc Drug Sciences